Enhanced permeability and retention of macromolecular drugs in solid tumors: A royal gate for targeted anticancer nanomedicines

被引:469
作者
Greish, Khaled [1 ]
机构
[1] Sojo Univ, Fac Pharmaceut Sci, Lab Microbiol & Oncol, Kumamoto 8600082, Japan
基金
日本学术振兴会;
关键词
EPR effect; nanomedicines; micelles; targeted anticancer therapy; macromolecular drugs;
D O I
10.1080/10611860701539584
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Over the past two decades cancer has ascended the causes of human death to be number one or two in many nations world wide. A major limitation inherent to most conventional anticancer chemotherapeutic agents is their lack of tumor selectivity. One way to achieve selective drug targeting to solid tumors is to exploit abnormalities of tumor vasculature, namely, hypervascularisation; aberrant vascular architecture; extensive production of vascular permeability factors stimulating extravasation within tumor tissues, and lack of lymphatic drainage. Maeda and his colleagues have extensively studied tumor vascular abnormalities in terms of active and selective delivery of anticancer drugs to tumor tissues, notably defining the enhanced permeability and retention effect (EPR effect) of macromolecular drugs in solid tumors. Due to their large molecular size, nanosized macromolecular anticancer drugs administered intravenously (i.v.) escape renal clearance. Often they can not penetrate the tight enclothelial junctions of normal blood vessels, but they can extravasate in tumour vasculature and become trapped in the tumor vicinity. With time the tumor concentration will build up reaching several folds higher than that of the plasma due to lack of efficient lymphatic drainage in solid tumor; an ideal application for EPR-based selective anticancer drug delivery. Establishing this principle hastened development of various polymer conjugates and polymeric micelles as well as multifunctional nanoparticles for targeted cancer chemotherapy. Indeed this selective high local concentration of nanosized anticancer drugs in tumor tissues has proven superior in therapeutic effect with minimal side effects in both preclinical and clinical settings. In this review the mechanisms and factors involved in the EPR effect, as well as the uniqueness of nanoscale drugs for tumor targeting through EPR effect, will be discussed in detail.
引用
收藏
页码:457 / 464
页数:8
相关论文
共 74 条
  • [1] [Anonymous], 1986, Protein Tailoring for Food and Medical Uses
  • [2] ARUN I, 2007, BIOMATERIALS, V10, P1871
  • [3] Tumor vascular permeabilization by vascular-targeting photosensitization: Effects, mechanism, and therapeutic implications
    Chen, B
    Pogue, BW
    Luna, JM
    Hardman, RL
    Hoopes, PJ
    Hasan, T
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (03) : 917 - 923
  • [4] Courtice FC, 1963, LYMPH LYMPHATIC SYST, P89
  • [5] Biphasic effect of hydrogen peroxide on skeletal muscle arteriolar tone via activation of endothelial and smooth muscle signaling pathways
    Cseko, C
    Bagi, Z
    Koller, A
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 2004, 97 (03) : 1130 - 1137
  • [6] DAVIES CL, 2002, BRIT J CANCER, V6, P1639
  • [7] Photodynamic therapy
    Dougherty, TJ
    Gomer, CJ
    Henderson, BW
    Jori, G
    Kessel, D
    Korbelik, M
    Moan, J
    Peng, Q
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (12): : 889 - 905
  • [8] Duncan, 1999, Pharm Sci Technol Today, V2, P441, DOI 10.1016/S1461-5347(99)00211-4
  • [9] Fang J, 2002, CANCER RES, V62, P3138
  • [10] Fingar V H, 1996, J Clin Laser Med Surg, V14, P323